Evidence map›Paper›PMID 40143839›Full record

ReviewGHM open2023

Seven steps in the value chain of health products for equitable access and delivery in low- and middle-income countries.

Eiichi Shimizu, Yuta Yokobori, Kazuki Miyazaki, Kaori Ohara, Megumi Fujii, Tomoko Nishioka, Noriko Fujita

Abstract readReview
In one paragraph

Review in GHM open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eiichi ShimizuBureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Yuta YokoboriBureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Kazuki MiyazakiBureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Kaori OharaBureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Megumi FujiiBureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Tomoko NishiokaBureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Noriko FujitaBureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The introduction of health products to low- and middle-income countries (LMICs) is hindered by several barriers. Even when these barriers are overcome, improper use of health products can have a negative effect on health outcomes. Health products may go unused due to a mismatch of product needs as well as a lack of public infrastructure, spare parts and consumables, or trained technicians. This study presents a comprehensive framework of the essential steps for effectively delivering quality health products to people in need based on our document reviews and case studies. We divide the value chain of health products into seven steps: 1) situation analysis, 2) research and development, 3) regulatory authorization, 4) selection and prioritization, 5) public procurement, 6) distribution and storage, and 7) health service delivery. We find that the practice of undertaking one step at a time leads to enormous costs in terms of time and resources, often with little success. Failed attempts sometimes necessitate starting over from the beginning. Therefore, it is important to attempt each step while looking ahead to the end through the entire chain of seven steps. More in-depth analysis and lessons from best practices for each of the seven steps may need to be investigated further to consider possible interventions.

Indexed as

access and deliverydeveloping countrieshealth productsmedical devicesuniversal health coverage

Identifiers

PMID40143839
PMCPMC11933981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.